Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024-Reference-Cited by-同舟云学术

Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024

Published:2024-08-01 Issue:31 Volume:29 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Rodrigues Carla¹²³,Bouchez Valérie¹²³,Soares Anaïs⁴,Trombert-Paolantoni Sabine⁵,Aït El Belghiti Fatima⁶,Cohen Jérémie F⁷⁸,Armatys Nathalie²³,Landier Annie²³,Blanchot Thomas⁴,Hervo Marie⁴,Toubiana Julie⁹⁸²³,Brisse Sylvain⁹²³,

Affiliation:

1. These authors contributed equally to this work and share first authorship.

2. National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France

3. Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France

4. Laboratoire Eurofins Biomnis, Lyon, France

5. Laboratoire Cerba, Saint Ouen l’Aumône, France

6. Santé publique France, Infectious Diseases Department, The French Public Health Agency, Saint-Maurice, France

7. Centre for Research in Epidemiology and Statistics (Inserm UMR 1153), Université Paris Cité, Paris, France

8. Department of General Paediatrics and Paediatric Infectious Diseases, Université Paris Cité, Hôpital Necker-Enfants Malades, APHP, Paris, France

9. These authors co-supervised the work and share last authorship.

Abstract

As other European countries, France is experiencing a resurgence of pertussis in 2024. Between 1 January and 31 May 2024, 5,616 (24.9%) positive Bordetella pertussis qPCR tests were identified, following a 3-year period of almost null incidence. Of 67 cultured and whole genome sequenced B. pertussis isolates, 66 produced pertactin and 56 produced FIM2, in contrast to pre-COVID-19 years. One isolate of genotype Bp-AgST4 was resistant to macrolides. Pertussis resurgence may favour isolates that produce FIM2 and pertactin.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Reference20 articles.

1. Severe pertussis in childhood: update and controversy - systematic review.;Machado;Rev Paul Pediatr,2019

2. Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020.;Matczak;Euro Surveill,2022

3. Monitoring the impact of vaccination on pertussis in infants using an active hospital-based pediatric surveillance network: results from 17 years’ experience, 1996-2012, France.;Tubiana;Pediatr Infect Dis J,2015

4. Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018.;Bouchez;Euro Surveill,2021

5. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin.;Bouchez;Vaccine,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the editor: Is the acellular pertussis vaccine driving the increase in severe whooping cough cases in children?;Eurosurveillance;2024-09-12